Incyte (INCY) Gross Profit Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 411.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.16% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 4.34% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 51.16% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 15.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.82% |
| Dec 31, 2025 | 16.89% |
| Sep 30, 2025 | 18.12% |
| Jun 30, 2025 | 9.71% |
| Mar 31, 2025 | 12.36% |
| Dec 31, 2024 | 10.01% |
| Sep 30, 2024 | 10.81% |
| Jun 30, 2024 | 13.15% |
| Mar 31, 2024 | 12.52% |
| Dec 31, 2023 | 7.80% |
| Sep 30, 2023 | 13.57% |
| Jun 30, 2023 | 10.62% |
| Mar 31, 2023 | 11.58% |
| Dec 31, 2022 | 16.61% |
| Sep 30, 2022 | 13.80% |
| Jun 30, 2022 | 19.81% |
| Mar 31, 2022 | 13.27% |
| Dec 31, 2021 | 17.72% |
| Sep 30, 2021 | 22.08% |
| Jun 30, 2021 | 10.37% |
| Mar 31, 2021 | 16.48% |
| Dec 31, 2020 | 21.32% |
| Sep 30, 2020 | 17.71% |
| Jun 30, 2020 | 28.83% |
| Mar 31, 2020 | 13.59% |
| Dec 31, 2019 | 21.26% |
| Sep 30, 2019 | 27.90% |
| Jun 30, 2019 | 28.86% |
| Mar 31, 2019 | 22.67% |
| Dec 31, 2018 | 28.94% |
| Sep 30, 2018 | 33.25% |
| Jun 30, 2018 | 46.88% |
| Mar 31, 2018 | 32.57% |
| Dec 31, 2017 | 51.40% |
| Sep 30, 2017 | 22.01% |
| Jun 30, 2017 | 45.50% |
| Mar 31, 2017 | 60.31% |
| Dec 31, 2016 | 46.85% |
| Sep 30, 2016 | 43.15% |
| Jun 30, 2016 | 32.08% |
| Mar 31, 2016 | 53.69% |
| Dec 31, 2015 | 27.21% |
| Sep 30, 2015 | 43.74% |
| Jun 30, 2015 | 21.90% |
| Mar 31, 2015 | 62.88% |
| Dec 31, 2014 | 61.44% |
| Sep 30, 2014 | 127.62% |
| Jun 30, 2014 | 80.90% |
| Mar 31, 2014 | 42.03% |
| Dec 31, 2013 | 4.10% |
| Sep 30, 2013 | 71.88% |
| Jun 30, 2013 | 26.88% |
| Mar 31, 2013 | 60.44% |